Diagnosis and management of schistosomiasis

The authors’ studies on schistosomiasis have received financial support from various sources including: the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases; the National Health and Medical Research Council of Australia; the Wellcome Trust (UK); the Sandler Foundation (USA); the Dana Foundation (USA); and the National Institute of Allergy and Infectious Diseases.

[1]  M. Tanner,et al.  ACTs for schistosomiasis: do they act? , 2010, The Lancet. Infectious diseases.

[2]  K. Kloetzel.  Mortality in chronic splenomegaly due to Schistosomiasis mansoni: follow-up study in a Brazilian population. , 1967, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  G. Williams,et al.  Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China. , 1997, The American journal of tropical medicine and hygiene.

[4]  Gail M. Williams,et al.  Schistosomiasis in the People's Republic of China: the Era of the Three Gorges Dam , 2010, Clinical Microbiology Reviews.

[5]  M. Tanner,et al.  Measuring exposure to Schistosoma japonicum in China. III. Activity diaries, snail and human infection, transmission ecology and options for control. , 2000, Acta tropica.

[6]  J. Lambertucci.  Acute schistosomiasis: clinical, diagnostic and therapeutic features. , 1993, Revista do Instituto de Medicina Tropical de Sao Paulo.

[7]  L. M. Oliveira,et al.  Evaluation of polymerase chain reaction as an additional tool for the diagnosis of low-intensity Schistosoma mansoni infection. , 2010, Diagnostic microbiology and infectious disease.

[8]  S. McGarvey,et al.  Child growth, nutritional status, and schistosomiasis japonica in Jiangxi, People's Republic of China. , 1993, The American journal of tropical medicine and hygiene.

[9]  G. Poggensee,et al.  Female genital schistosomiasis: facts and hypotheses. , 2001, Acta tropica.

[10]  R. Barsoum.  The changing face of schistosomal glomerulopathy. , 2004, Kidney international.

[11]  M. Tanner,et al.  Artemisinins for schistosomiasis and beyond. , 2007, Current opinion in investigational drugs.

[12]  Gail M. Williams,et al.  A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. , 2008, Bulletin of the World Health Organization.

[13]  S. Botros,et al.  Effect of praziquantel on the immature stages of Schistosoma haematobium. , 2005, International journal for parasitology.

[14]  S. McGarvey,et al.  Immunity and morbidity in schistosomiasis japonicum infection. , 1996, The American journal of tropical medicine and hygiene.

[15]  C. King,et al.  Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis , 2005, The Lancet.

[16]  Xiaonong Zhou,et al.  A strategy to control transmission of Schistosoma japonicum in China. , 2009, The New England journal of medicine.

[17]  Luc Kestens,et al.  Human schistosomiasis , 2006, The Lancet.

[18]  A. Cheever.  A quantitative post-mortem study of Schistosomiasis mansoni in man. , 1968, The American journal of tropical medicine and hygiene.

[19]  J. Bennett,et al.  Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. , 1996, The American journal of tropical medicine and hygiene.

[20]  E. Bottieau,et al.  Imported Katayama fever: clinical and biological features at presentation and during treatment. , 2006, The Journal of infection.

[21]  Yuesheng Li,et al.  sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica , 2008, International journal for parasitology.

[22]  P. Jordan,et al.  Experimental schistosomiasis in primates in Tanzania. Preliminary observations on the susceptibility of the baboon Papio anubis to Schistosoma haematobium and Schistosoma mansoni. , 1967, Bulletin of the World Health Organization.

[23]  Jürg Utzinger,et al.  Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis , 2008, Current opinion in infectious diseases.

[24]  P. Chiodini,et al.  Development of a new assay for the diagnosis of schistosomiasis, using cercarial antigens. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  T. Wynn,et al.  Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? , 2006, Trends in parasitology.

[26]  J. Utzinger,et al.  Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Eli Schwartz,et al.  Travel-related Schistosomiasis Acquired in Laos , 2009, Emerging infectious diseases.

[28]  M. Todd,et al.  Drugs for the control of parasitic diseases: current status and development in schistosomiasis. , 2003, Trends in parasitology.

[29]  I. Elsebai,et al.  Parasites in the etiology of cancer—bilharziasis and bladder cancer , 1977, CA: a cancer journal for clinicians.

[30]  C. Shiff,et al.  Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. , 2009, The American journal of tropical medicine and hygiene.

[31]  S. Mas‐Coma,et al.  Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. , 2009, Veterinary parasitology.

[32]  T. Day,et al.  Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. , 1999, The American journal of tropical medicine and hygiene.

[33]  D. Bundy,et al.  Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren. , 1999, The American journal of tropical medicine and hygiene.

[34]  P. Coelho,et al.  Development and Evaluation of a Sensitive PCR-ELISA System for Detection of Schistosoma Infection in Feces , 2010, PLoS neglected tropical diseases.

[35]  Gail M. Williams,et al.  A drug-based intervention study on the importance of buffaloes for human Schistosoma japonicum infection around Poyang Lake, People's Republic of China. , 2006, The American journal of tropical medicine and hygiene.

[36]  R. Sturrock,et al.  Schistosoma japonicum and S. japonicum-like infections: epidemiology, clinical and pathological aspects. , 1993 .

[37]  P. Mwinzi,et al.  Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. , 2010, The Lancet. Infectious diseases.

[38]  J. Utzinger,et al.  An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. , 2009, Acta tropica.

[39]  G. Poggensee,et al.  Female genital schistosomiasis: a neglected risk factor for the transmission of HIV? , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[40]  A. Rabello.  Diagnosing schistosomiasis. , 1997, Memorias do Instituto Oswaldo Cruz.

[41]  A. Deelder,et al.  Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[42]  R. Hayes,et al.  Admissions to a rural hospital in the West Nile District of Uganda over a 27 year period. , 1986, The Journal of tropical medicine and hygiene.

[43]  J. Sippel,et al.  Schistosoma mansoni and S. haematobium infections in Egypt. III. Extrahepatic pathology. , 1978, The American journal of tropical medicine and hygiene.

[44]  M. Tanner,et al.  The morbidity attributable to Schistosoma japonicum infection in 3 villages in Dongting Lake region, Hunan Province, PR China , 1996, Tropical medicine & international health : TM & IH.

[45]  F. J. Carod-Artal.  Neurological complications of Schistosoma infection. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[46]  M. Tanner,et al.  Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. , 1998, The American journal of tropical medicine and hygiene.

[47]  A. van Gompel,et al.  Schistosomiasis in travellers and migrants. , 2011, Travel medicine and infectious disease.

[48]  C. Grevelding,et al.  Diagnosing Schistosomiasis by Detection of Cell-Free Parasite DNA in Human Plasma , 2009, PLoS neglected tropical diseases.

[49]  M. Tanner,et al.  A potential impact of climate change and water resource development on the transmission of Schistosoma japonicum in China. , 2005, Parassitologia.

[50]  M. Doenhoff.  A role for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis , 1997, Parasitology.

[51]  C. King,et al.  The unacknowledged impact of chronic schistosomiasis , 2008, Chronic illness.

[52]  A. Yosry.  Schistosomiasis and neoplasia. , 2006, Contributions to microbiology.

[53]  Anton Simeonov,et al.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.

[54]  N Katz,et al.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.

[55]  D. McManus,et al.  Katayama syndrome. , 2007, The Lancet. Infectious diseases.

[56]  B. Abudho,et al.  Evaluation of Urine CCA Assays for Detection of Schistosoma mansoni Infection in Western Kenya , 2011, PLoS neglected tropical diseases.

[57]  O. D. Standen.  Experimental schistosomiasis; maintenance of Schistosoma mansoni in the laboratory, with some notes on experimental infection with S. haematobium. , 1949, Annals of tropical medicine and parasitology.

[58]  Gail M. Williams,et al.  Current concepts - Schistosomiasis , 2002 .

[59]  R. Cheung,et al.  Caution with praziquantel in neurocysticercosis. , 1997, Stroke.

[60]  X. Shuhua,et al.  Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. , 2005 .

[61]  Jürg Utzinger,et al.  Diagnostic dilemmas in helminthology: what tools to use and when? , 2009, Trends in parasitology.

[62]  Gail M Williams,et al.  Schistosomiasis elimination: lessons from the past guide the future. , 2010, The Lancet. Infectious diseases.

[63]  T. Wynn,et al.  Immunopathology of schistosomiasis mansoni in mice and men. , 2000, Immunology today.

[64]  T. Ferrari.  Involvement of central nervous system in the schistosomiasis. , 2004, Memorias do Instituto Oswaldo Cruz.

[65]  D. Schuppan,et al.  Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease , 1992, Hepatology.

[66]  A. Deelder,et al.  Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. , 1999, The American journal of tropical medicine and hygiene.

[67]  S. Xiao.  Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. , 2005, Acta tropica.

[68]  M. O. Rocha,et al.  Pulmonary manifestations in the initial phase of schistosomiasis mansoni. , 1995, Revista do Instituto de Medicina Tropical de Sao Paulo.

[69]  D. Karanja,et al.  Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya , 2009, Tropical medicine & international health : TM & IH.

[70]  R. Sturrock,et al.  Schistosoma mansoni: pathological and clinical aspects. , 1993 .

[71]  D. McManus,et al.  Immunopathogenesis of human schistosomiasis , 2009, Parasite immunology.

[72]  D. Bradley,et al.  The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. II. Hospital investigation of a sample from the Panyagoro community. , 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[73]  E. Loker.  A comparative study of the life-histories of mammalian schistosomes , 1983, Parasitology.

[74]  M. Taylor,et al.  Comparison of the Infectivity and Pathogenicity of six species of African Schistosomes and their Hybrids 2. Baboons , 1973, Journal of Helminthology.

[75]  T. Nash,et al.  Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. , 1988, The American journal of tropical medicine and hygiene.

[76]  N. Spannbrucker,et al.  Schistosoma mansoni ‐related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters , 1997, Tropical medicine & international health : TM & IH.

[77]  T. Wynn,et al.  Immunopathogenesis of schistosomiasis , 2004, Immunological reviews.

[78]  C. la Vecchia,et al.  Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. , 1998, British Journal of Cancer.

[79]  Marcel Tanner,et al.  Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. , 2006, The Lancet. Infectious diseases.

[80]  S. McGarvey,et al.  Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: a randomized trial of praziquantel versus placebo. , 1996, The American journal of tropical medicine and hygiene.

[81]  Marcel Tanner,et al.  Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. , 2002, Bulletin of the World Health Organization.

[82]  J. Utzinger,et al.  Helminth infections of the central nervous system occurring in Southeast Asia and the Far East. , 2010, Advances in parasitology.

[83]  H. Bang,et al.  Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. , 2011, The American journal of tropical medicine and hygiene.

[84]  M. Tanner,et al.  Screening for schistosomiasis with questionnaires. , 2002, Trends in parasitology.

[85]  M. Koraitim,et al.  Changing age incidence and pathological types of schistosoma-associated bladder carcinoma. , 1995, The Journal of urology.

[86]  A. Bryceson,et al.  Lesions of schistosomiasis mimicking warts on the vulva. , 1993, BMJ.

[87]  A. D. dos Reis,et al.  [Immunodiagnosis in schistosomiasis]. , 1971, AMB : revista da Associacao Medica Brasileira.

[88]  O. Toure,et al.  Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children , 2009, PloS one.

[89]  M. O. Rocha,et al.  Gastro-intestinal manifestations of the initial phase of schistosomiasis mansoni. , 1995, Annals of tropical medicine and parasitology.

[90]  B. Gryseels,et al.  The morbidity of schistosomiasis mansoni in Maniema (Zaire). , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.